DATE: 
VENUE: 
ORGANIZER: 

B'\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\NNATIONAL BUREAU OF ECONOMIC RESEARCH\R\N\R\N\R\N\R\N\R\N\R\N<!--\R\N /* FONT DEFINITIONS */\R\N @FONT-FACE\R\N\T{FONT-FAMILY:UNIVERS;\R\N\TPANOSE-1:0 0 0 0 0 0 0 0 0 0;\R\N\TMSO-FONT-ALT:ARIAL;\R\N\TMSO-FONT-CHARSET:0;\R\N\TMSO-GENERIC-FONT-FAMILY:SWISS;\R\N\TMSO-FONT-FORMAT:OTHER;\R\N\TMSO-FONT-PITCH:VARIABLE;\R\N\TMSO-FONT-SIGNATURE:3 0 0 0 1 0;}\R\N /* STYLE DEFINITIONS */\R\N P.MSONORMAL, LI.MSONORMAL, DIV.MSONORMAL\R\N\T{MSO-STYLE-PARENT:"";\R\N\TMARGIN:0IN;\R\N\TMARGIN-BOTTOM:.0001PT;\R\N\TMSO-PAGINATION:WIDOW-ORPHAN;\R\N\TFONT-SIZE:12.0PT;\R\N\TFONT-FAMILY:"TIMES NEW ROMAN";\R\N\TMSO-FAREAST-FONT-FAMILY:"TIMES NEW ROMAN";}\R\NP.MSOPLAINTEXT, LI.MSOPLAINTEXT, DIV.MSOPLAINTEXT\R\N\T{MARGIN:0IN;\R\N\TMARGIN-BOTTOM:.0001PT;\R\N\TMSO-PAGINATION:WIDOW-ORPHAN;\R\N\TFONT-SIZE:10.0PT;\R\N\TFONT-FAMILY:"COURIER NEW";\R\N\TMSO-FAREAST-FONT-FAMILY:"TIMES NEW ROMAN";}\R\N@PAGE SECTION1\R\N\T{SIZE:8.5IN 11.0IN;\R\N\TMARGIN:1.0IN 1.0IN 1.0IN 1.0IN;\R\N\TMSO-HEADER-MARGIN:.5IN;\R\N\TMSO-FOOTER-MARGIN:.5IN;\R\N\TMSO-PAPER-SOURCE:0;}\R\NDIV.SECTION1\R\N\T{PAGE:SECTION1;}\R\N-->\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N \R\N \R\N NATIONAL\R\N BUREAU OF ECONOMIC RESEARCH\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N LOCATION\R\N OF BIOPHARMACEUTICAL ACTIVITY PRE-CONFERENCE\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N IAIN\R\N COCKBURN AND MATTHEW SLAUGHTER, ORGANIZERS\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N JULY\R\N 20, 2007\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N NBER\R\N \R\N \R\N \R\N \R\N \R\N 2ND\R\N FLOOR CONFERENCE ROOM\R\N \R\N \R\N \R\N \R\N 1050\R\N MASSACHUSETTS AVENUE\R\N \R\N \R\N \R\N \R\N CAMBRIDGE,\R\N MASSACHUSETTS\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N PROGRAM\R\N \R\N \R\N\R\N\R\N\XA0\R\N\R\N\R\N \R\N \R\N FRIDAY, JULY 20:\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA08:45 AM\R\N \R\N \R\N COFFEE AND PASTRIES\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA09:15 AM\R\N \R\N \R\N INTRODUCTION:\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N IAIN COCKBURN, BOSTON UNIVERSITY AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N MATTHEW SLAUGHTER, DARTMOUTH COLLEGE AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA09:30 AM\R\N \R\N \R\N PIERRE AZOULAY, MIT AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N ARIEL FISHMAN, COLUMBIA UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N DOCTORS, $$ AND DRUG DEVELOPMENT: THE RISE OF\R\N FOR-PROFIT EXPERIMENTAL MEDICINE\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 10:00 AM\R\N \R\N \R\N ERNST BERNDT, MIT AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N FABIO THIERS, MIT\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N FACTORS AFFECTING THE CHANGING GLOBAL LOCATION\R\N OF CLINICAL TRIALS: A SURVEY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 10:30 AM\R\N \R\N \R\N BEAK\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 10:45 AM\R\N \R\N \R\N MARIE THURSBY, GEORGIA INSTITUTE OF TECHNOLOGY\R\N AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N JERRY THURSBY, EMORY UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N INTERNATIONAL R&D LOCATION DECISIONS OF\R\N BIOPHARMA FIRMS: SURVEY EVIDENCE\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 11:15 AM\R\N \R\N \R\N KIRA FABRIZIO AND L.G. THOMAS, EMORY UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N TACIT DEMAND AND INNOVATION IN THE GLOBAL\R\N PHARMACEUTICAL INDUSTRY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 11:45 AM\R\N \R\N \R\N NICK ARGYRES, BOSTON UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N ELIAS BRUEGMANN, HARVARDUNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N JEFF FURMAN, BOSTON UNIVERSITY AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N POST-MERGER R&D RE-ORGANIZATION IN THE\R\N GLOBAL PHARMACEUTICAL INDUSTRY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 12:15 PM\R\N \R\N \R\N LUNCH\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA01:15 PM\R\N \R\N \R\N JUAN ALCACER, HARVARD UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N JOHN CANTWELL AND MICHELLE GITTELMAN, RUTGERS\R\N UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N THE ROLE OF LICENSING IN THE GLOBALIZATION OF\R\N BIO-PHARMACEUTICALS: AN ANALYSIS OF THE GEOGRAPHY OF DRUG DEVELOPMENT AND\R\N CLINICAL TRIALS\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA01:45 PM\R\N \R\N \R\N ASHISH ARORA, CARNEGIE MELLON UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N LEE BRANSTETTER, CARNEGIE MELLON UNIVERSITY AND\R\N NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N CHIRANTAN CHATTERJEE, CAREGIE MELLON UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N FUNDAMENTAL PATENT REFORM AND THE PRIVATE\R\N RETURNS TO R&D \X96 THE CASE OF INDIAN PHARMACEUTICALS\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA02:15 PM\R\N \R\N \R\N KELLEY PORTER, QUEENS UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N KJERSTEN BUNKER WHITTINGTON, STANFORD\R\N UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N JASON OWEN-SMITH, UNIVERSITY OF MICHIGAN\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N WALTER W. POWELL, STANFORD UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N WHICH SECRETS NEED TO BE IN THE AIR?:\XA0 AN ANALYSIS OF THE GEOGRAPHIC DIVISION OF\R\N LABOR IN THE BIOPHARMACEUTICAL INDUSTRY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA02:45 PM\R\N \R\N \R\N BREAK\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA03:00 PM\R\N \R\N \R\N MERCEDES DELGADO-GARCIA, HARVARD UNIVERSITY\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N MARGARET KYLE, LONDON BUSINESS SCHOOL AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N ANITA MCGAHAN, UNIVERSITY OF TORONTO\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N HOW LIBERALIZED INTERNATIONAL TRADE REGULATIONS\R\N CHANGE THE LOCATION OF PHARMACEUTICAL ACTIVITIES AROUND THE WORLD\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA03:30 PM\R\N \R\N \R\N MEGAN MACGARVIE, BOSTON UNIVERSITY AND NBER\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N PAMINA\R\N KOENIG, UNIVERSIT\XE9 PARIS X\XA0 \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N DOMESTIC REGULATORY POLICY AND THE\R\N INTERNATIONAL LOCATION OF PHARMACEUTICAL MANUFACTURING\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \XA04:00 PM\R\N \R\N \R\N ADJOURN\R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N \R\N 7/17/07\R\N \R\N \R\N \R\N \R\N \R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N\R\N'